Mri-guided adaptive radiation for locally advanced pancreatic cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a new, precise form of radiation therapy for locally advanced pancreatic cancer that uses MRI to target the tumor more accurately. It aims to improve treatment effectiveness while reducing damage to surrounding healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older with a confirmed diagnosis of pancreatic cancer (adenocarcinoma).
- You have completed at least 4 cycles (but no more than 8) of induction chemotherapy, such as FOLFIRINOX or Gemzar-Abraxane.
- The cancer is locally advanced (has not spread to other organs), and your CA 19-9 blood marker level is below 1000.
- You are in generally good health (able to do light activity) and can undergo MRI scans without any metal implants or severe claustrophobia.
- You have not had radiation therapy to the abdomen before and do not have certain other serious medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests giving specific chemotherapy in sequence, then using MRI-guided focused radiation to treat locally advanced, non-removable pancreatic cancer. It may help shrink or control the tumor while aiming radiation more precisely using MRI.
This trial tests a special, high-dose radiation treatment for pancreatic cancer that has not spread but cannot be removed with surgery. The goal is to shrink the tumor and improve control of the cancer in the abdomen.
This trial tests whether combining targeted radiation with an at-home “tumor treating fields” device can better control locally advanced pancreatic cancer. It may help by attacking cancer cells in more than one way after prior chemotherapy.
This trial tests whether giving a strong, focused dose of radiation can help people with locally advanced pancreatic cancer that has shrunk or stayed stable with first-line chemotherapy. It aims to improve outcomes for those who cannot have surgery.
This trial tests a new treatment called DaRT, which places tiny radioactive devices directly into your pancreatic tumor. It is for people with locally advanced pancreatic cancer that has not spread, after they have already had standard chemotherapy.
This trial tests a precise type of radiation therapy guided by MRI for people with locally advanced pancreatic cancer. It aims to treat the tumor while protecting nearby healthy tissue, potentially improving outcomes after chemotherapy.
Hear when a new Locally Advanced Pancreatic Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.